Experimental treatments
for aHO

Overview

While there has been some progress in the treatment of acquired hypothalamic obesity (aHO) in recent years, clinical trials are underway to test additional medications for people with this rare disease.

Bivamelagon

Bivamelagon is an experimental oral therapy being developed to help people with aHO reach and maintain a healthy weight. It works to restore normal activity in the MC4R signalling pathway, which controls appetite and energy use.

Learn more